20 LATEST RESOURCES (53 INDEXED)
Comparative Harms Assessments for Cannabis, Alcohol, and Tobacco: Risk for Psychosis, Cognitive Impairment, and Traffic Accident · July 2022
Articles
Drug Science, Policy and Law
Disentangling the Consequences of Systemic Racism and Clinical Paranoia to Promote Effectiveness of a Cognitive-Behavioral Intervention for Persecutory Delusions in Minoritized Individuals: A Case-Example · July 2023
Articles
Clinical Case Studies
Interpretation Bias in Paranoia: A Systematic Review and Meta-Analysis · October 2020
Articles
Clinical Psychological Science
Continuities and Discontinuities in the Cognitive Mechanisms Associated with Clinical and Nonclinical Auditory Verbal Hallucinations · January 2022
Articles
Clinical Psychological Science
Network Pharmacology and Molecular Docking Analysis on Targets and Mechanisms of Berberine in Atypical Antipsychotic-Induced Metabolic Syndrome · October 2022
Articles
Natural Product Communications
Body Mass Index as a Determinant of Clozapine Plasma Concentrations: A Pharmacokinetic-Based Hypothesis · February 2021
Abstracts
Journal of Psychopharmacology
Effects of Omega-3 Polyunsaturated Fatty Acids Supplements on Psychopathology and Metabolic Parameters in Schizophrenia: A Meta-Analysis of Randomized Controlled Trials · February 2021
Abstracts
Journal of Psychopharmacology
Influence of More than 5 Years of Continuous Exposure to Antipsychotics on Cerebral Functional Connectivity of Chronic Schizophrenia · February 2020
Articles
Canadian Journal of Psychiatry
Mortality and Revascularization among Myocardial Infarction Patients with Schizophrenia: A Population-Based Cohort Study · February 2020
Articles
Canadian Journal of Psychiatry
Identifying Unique Subgroups of High-Cost Patients with Schizophrenia: A Population-Based Study Using Latent Class Analysis · June 2023
Articles
Health Services Insights
Do Anxiety Symptoms Mediate the Association Between Cannabis Use Frequency and Psychotic-Like Experiences in Emerging Adult Undergraduates? · May 2023
Articles
Canadian Journal of Psychiatry
A Randomized Controlled Trial of Vitamin D Supplementation in Iranian Patients with Schizophrenia: Effects on Serum Levels of Glycogen Synthase Kinase-3B and Symptom Severity · August 2023
Abstracts
International Journal of Psychiatry in Medicine
Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review · March 2023
Articles
Journal of Geriatric Psychiatry and Neurology
Flourishing, Psychological Distress and Internalized Stigma among Parents of an Adult Son or Daughter with Schizophrenia · April 2023
Articles
International Journal of Social Psychiatry
Visualizing Classification of Drugs Used in Psychotic Disorders: A ‘Subway Map’ Representing Mechanisms, Established Classes and Informal Categories · August 2022
Articles
Journal of Psychopharmacology
Clinical Correlates of Early Onset Antipsychotic Treatment Resistance · October 2022
Articles
Journal of Psychopharmacology
Effects of Clozapine Treatment on the Improvement of Substance Use Disorders Other than Nicotine in Individuals with Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis · December 2022
Articles
Journal of Psychopharmacology
Clozapine-Associated Neutropenia Following Augmentation with Sodium Valproate · May 2021
Articles
SAGE Open Medical Case Reports
A New Genetic Locus for Antipsychotic-Induced Weight Gain: A Genome-Wide Study of First-Episode Psychosis Patients Using Amisulpride (from the OPTiMiSE Cohort) · March 2020
Articles
Journal of Psychopharmacology
Symptomatic and Functional Outcomes After Treatment with Paliperidone Palmitate 3-Month Formulation for 52 Weeks in Patients with Clinically Stable Schizophrenia · May 2020
Articles
Therapeutic Advances in Psychopharmacology